KO:NYSECoca-Cola Company (The) Analysis
Data as of 2026-03-09 - not real-time
$77.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The Coca‑Cola stock is trading at $77.55, comfortably above its 50‑day (74.83) and 200‑day (70.87) moving averages but just shy of the 20‑day average (79.10), indicating a medium‑term bullish bias with short‑term pressure. Technicals show a neutral RSI (49) and a bearish MACD histogram, while price sits near a solid support zone at $76.01 and faces resistance around $82, suggesting limited downside but upside potential if it can break the resistance level.
Fundamentally, KO carries a forward PE of 22.38 and a dividend yield of 2.67% with a 67% payout ratio, supported by a strong ROE of 43% and a 5% organic revenue growth year‑over‑year. However, the balance sheet is leveraged (debt‑to‑equity ≈ 140) and free cash flow is currently negative, which tempers the attractiveness despite an analyst consensus “buy” and a median price target of $85, implying roughly a 7‑8% upside from today’s price.
Fundamentally, KO carries a forward PE of 22.38 and a dividend yield of 2.67% with a 67% payout ratio, supported by a strong ROE of 43% and a 5% organic revenue growth year‑over‑year. However, the balance sheet is leveraged (debt‑to‑equity ≈ 140) and free cash flow is currently negative, which tempers the attractiveness despite an analyst consensus “buy” and a median price target of $85, implying roughly a 7‑8% upside from today’s price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near support at $76.01
- Bearish MACD histogram and price below 20‑day SMA
- Q4 earnings beat and dividend increase reinforce stability
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median target $85 (~7.5% upside)
- Organic revenue growth of 5% and guidance for continued earnings expansion
- Strong dividend yield and 64‑year dividend streak
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Defensive consumer‑staple positioning with global brand equity
- High ROE (43%) and consistent cash‑flow generation despite short‑term free‑cash‑flow dip
- Ability to sustain dividend payouts and potential deleveraging over time
Key Metrics & Analysis
Financial Health
Revenue Growth2.40%
Profit Margin27.34%
P/E Ratio25.5
ROE43.32%
ROA9.15%
Debt/Equity139.79
P/B Ratio10.4
Op. Cash Flow$7.4B
Free Cash Flow$-1461250048
Technical Analysis
TrendBullish
RSI49.0
Support$76.01
Resistance$82.00
MA 20$79.10
MA 50$74.83
MA 200$70.87
MACDBearish
VolumeStable
Fear & Greed Index100
Valuation
Fair Value$11.09
Target Price$83.36
Upside/Downside7.50%
GradeFair
TypeBlend
Dividend Yield2.67%
Risk Assessment
Beta0.05
Volatility17.93%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.